期刊文献+

自体DC-CIK细胞过继免疫治疗肾癌的护理 被引量:8

Nursing on adoptive immunotherapy with autologous cytokine-induced killer cells and dendritic cells for patients with renal cell carcmoma
暂未订购
导出
摘要 目的:探讨DC-CIK细胞过继免疫治疗肾癌所实施的相应护理措施。方法;选取我院2010年1月~2011年12月30例接受细胞过继免疫治疗肾癌患者,根据各个治疗阶段的要求采取相应的护理措施,通过加强护理干预,严格遵守回输各项操作规程,确保治疗有效的进行。结果:30例术后肾癌中,均圆满完成治疗,病情稳定,顺利出院。结论:护理质量的优劣是影响细胞免疫治疗效果和患者预后的重要因素,给予全方位的整体护理,有利于提高患者的生活质量。 Objective:To investigate nursing measure of adoptive immunotherapy with cytokine-induced killer cells and DC cell with renal cell carcmoma.Methods:The clinical data of 30 infants after radical nephrectomy were retrospectively analyzed from January 2010 to December 2011.To carry on the whole nursing management through the clinical service and the various links systematization of nursing manages according to nursing needs at different stage,we take the appropriate nursing care and Strict implementation of all the standards and operations in ordr to ensure the efficiency of implement.Results:There was no severe complications and no mortality in treating and nursing 30 patients undergoing immunotherapy.Conclusion:The quality of nursing is the important factor for the effect of the cellular immunetherapy and prognosis of patients.Through systematic holistic nursing care,it was effective in improving the life quality of the sufferers.
出处 《护理实践与研究》 2012年第13期89-90,共2页 Nursing Practice and Research
关键词 肾癌 免疫治疗 护理 Renal cell carcinoma Adoptive immunotherapy Nursing
  • 相关文献

参考文献8

  • 1邹征云,刘宝瑞.树突状细胞瘤苗的制备与临床应用进展[J].肿瘤防治杂志,2004,11(11):1205-1209. 被引量:5
  • 2Sehmidt - Wolf IG, Lefterova P, Mehta BA, et al. Pheno typic char- acterization and identification of effector cells involved in tumor cell recognition of cytokine O induced killer cells [ J ]. Exp Hematol , 1993,21 (13) :1673 - 1679.
  • 3张嵩,王恩忠,白春学,徐永华.共培养的树突状细胞与CIK细胞的体外增殖和杀瘤活性研究[J].实验生物学报,2003,36(5):375-380. 被引量:14
  • 4Hirschowitz EA, Foedy T, Hidalogo GE, et al. Autologous dendritic cell vaccines for non - small - call lung cancer[ .I ]. Lung Caucer, 2007,57 (3) :365 - 372.
  • 5Wongkajomsilp A, Sangsuriyong S, Hongeng S,et al. Effective osteo- sarcoma cytolysis using cytokine - Induced killer cells pre - inocula- ted with tumor RNA - pulsed dendritic cells [ J ]. J Orthop Res, 2005,23 (6) : 1460 - 1466.
  • 6尹富华,鲍锋,梁辉,杨素芬,刘荣春,刘寅,运美江.肿瘤的CIK细胞过继免疫治疗观察及实验研究[J].辽宁中医药大学学报,2006,8(6):157-158. 被引量:8
  • 7程霞,张晓实,彭瑞清,丁娅,刘继彦,张念华,李志铭,苏义顺,曾益新.肿瘤负荷对CIK/IL-2临床疗效的影响[J].中国肿瘤临床,2005,32(15):847-848. 被引量:21
  • 8北京肿瘤生物中心.肿瘤细胞免疫治疗技术能够降低肾瘤术后转移率[EB/OL].(2011-4-27)[2012.2.19]http://www.zhongliucls.com/shenai/sazl一12893693.html.

二级参考文献63

  • 1[2]Schmidt-wolf IG,Lefterova P,Mehta BA,et al.Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells[J].Exp Hematol,1993,21 (13):1673
  • 2[3]Schmidt-woif IGH,Negrim RS,kiem HP,et al.Use of a SCLD mouse/Human lymphoma model to evaluate cytokine-induced killer cell with potentantitumor cell activity[J].J Exp,1991,174:139
  • 3[5]Lu PH,Negrin RS.A novel population of expanded human CD3-CD56-cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency[J].J Immunol,1994,153 (4):1687
  • 4Schmidt-Wolf IG, Lefterova P, Mehta BA, et al. Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells [J]. Exp Hematol, 1993, 21(13):1673~1679.
  • 5Linn YC, Hui KM. Cytokine-induced killer cells: NK-like T cells with cytotolytic specificity against leukemia [J]. Leuk Lymphoma, 2003, 44(9):1457~1462.
  • 6Schmidt-Wolf GD, Negrin RS, Schmidt-Wolf IG. Activated T cells and cytokine-induced CD3 +CD56 + killer cells [J]. Ann Hematol, 1997, 74(2):51~56.
  • 7Schmidt-Wolf IG, Finke S, Trojaneck B, et al. Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma[J]. BrJ Cancer, 1999, 81(6):1009~1016.
  • 8宋英晖 徐红薇 任欢.CIK细胞的生物学特性及体外抗肿瘤作用的研究[J].中国肿瘤生物治疗杂志,1997,4(3):190-190.
  • 9张蒙恩 陈志敏.CIK细胞的制备及检测[J].中国肿瘤生物治疗杂志,1997,4(3):184-184.
  • 10Marincola FM, Wang E, Herlyn M, et al. Tumor as elusive targets of T-cell-based active immunotherapy [J]. Trends Immunol,2003, 24(6):334 ~341.

共引文献41

同被引文献86

引证文献8

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部